Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway

Oncogene

Volumn 26, Issue 20, 2007, Pages 2851-2859

  Wang, L ^a   Kurosaki, T ^b,c   Corey, S J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

B cell antigen receptor; Jak; Lyn; STAT

Indexed keywords

B LYMPHOCYTE ANTIGEN; ENZYME INHIBITOR; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; LYMPHOCYTE ANTIGEN RECEPTOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN KINASE LYN; STAT PROTEIN; STAT3 PROTEIN; TYROSINE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NULL ALLELE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELLS, CULTURED; CHICKENS; DNA-BINDING PROTEINS; GRANULOCYTE COLONY-STIMULATING FACTOR; JANUS KINASES; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR;

EID: 34247866419     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210092     Document Type: Article

References (43)

1. Cao X, Tay A, Guy GR, Tan YH. (1996). Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16: 1595-1603.
2. Chaturvedi P, Reddy MV, Reddy EP. (1998). Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene 16: 1749-1758.
3. Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O. (1998). Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 91: 3734-3745.
4. Cirri P, Chiarugi P, Marra F, Raugei G, Camici G, Manao G et al. (1997). c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem Biophys Res Commun 239: 493-497.
5. Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML et al. (2003). Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells. Oncogene 22: 4102-4110.
6. Corey SJ, Dombrosky-Ferlan PM, Zuo S, Krohn E, Donnenberg AD, Zorich P et al. (1998). Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 273: 3230-3235.
7. de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L. (1999). STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells. Blood 94: 1108-1112.
8. DeFranco AL, Richards JD, Blum JH, Stevens TL, Law DA, Chan VW et al. (1995). Signal transduction by the B-cell antigen receptor. Ann NY Acad Sci 766: 195-201.
9. Dorsey JF, Cunnick JM, Lanehart R, Huang M, Kraker AJ, Bhalla KN et al. (2002). Interleukin-3 protects Bcr-Ab-ltransformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors. Leukemia 16: 1589-1595.
10. Fan H, Rothstein TL. (2001). Lymphokine dependence of STAT3 activation produced by surface immunoglobulin cross-linking and by phorbol ester plus calcium ionophore treatment in B cells. Eur J Immunol 31: 665-671.
11. Finbloom DS, Larner AC. (1995). Regulation of the Jak/STAT signalling pathway. Cell Signal 7: 739-745.
12. Hibbs ML, Harder KW, Armes J, Kountouri N, Quilici C, Casagranda F et al. (2002). Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med 196: 1593-1604.
13. Ihle JN. (1995). The Janus protein tyrosine kinases in hematopoietic cytokine signaling. Semin Immunol 7: 247-254.
14. Imada K, Leonard WJ. (2000). The Jak-STAT pathway. Mol Immunol 37: 1-11.
15. Ishikawa H, Tsuyama N, Abroun S, Liu S, Li FJ, Taniguchi O et al. (2002). Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. Blood 99: 2172-2178.
16. Kaptein A, Paillard V, Saunders M. (1996). Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem 271: 5961-5964.
17. Karras JG, Huo L, Wang Z, Frank DA, Zimmet JM, Rothstein TL. (1996a). Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes. J Immunol 157: 2299-2309.
18. Karras JG, Wang Z, Coniglio SJ, Frank DA, Rothstein TL. (1996b). Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site. J Immunol 157: 39-47.
19. Keshvara LM, Isaacson CC, Yankee TM, Sarac R, Harrison ML, Geahlen RL. (1998). Syk- and Lyn-dependent phosphoryl ation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J Immunol 161: 5276-5283.
20. Koay DC, Nguyen T, Sartorelli AC. (2002). Distinct region of the granulocyte colony-stimulating factor receptor mediates proliferative signaling through activation of Janus kinase 2 and p44/42 mitogen-activated protein kinase. Cell Signal 14: 239-247.
21. Kurosaki T, Maeda A, Ishiai M, Hashimoto A, Inabe K, Takata M. (2000). Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol Rev 176: 19-29.
22. Leonard WJ, O'Shea JJ. (1998). Jaks and STATs: biological implications. Annu Rev Immunol 16: 293-322.
23. Lund TC, Coleman C, Horvath E, Sefton BM, Jove R, Medveczky MM et al. (1999). The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity. Cell Signal 11: 789-796.
24. Mirnics ZK, Caudell E, Gao Y, Kuwahara K, Sakaguchi N, Kurosaki T et al. (2004). Microarray analysis of Lyn-deficient B cells reveals germinal center-associated nuclear protein and other genes associated with the lymphoid germinal center. J Immunol 172: 4133-4141.
25. Nelson KL, Rogers JA, Bowman TL, Jove R, Smithgall TE. (1998). Activation of STAT3 by the c-Fes protein-tyrosine kinase. J Biol Chem 273: 7072-7077.
26. Nicholson SE, Novak U, Ziegler SF, Layton JE. (1995). Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 86: 3698-3704.
27. Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y et al. (2001). Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 20: 6643-6650.
28. Pereira S, Lowell C. (2003). The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J Immunol 171: 1319-1327.
29. Saharinen P, Vihinen M, Silvennoinen O. (2003). Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. Mol Biol Cell 14: 1448-1459.
30. Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, Burkhardt AL et al. (1994). Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci USA 91: 9524-9528.
31. Sarmay G, Koncz G, Pecht I, Gergely J. (1997). Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell. Immunol Lett 57: 159-164.
32. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, Wijnands E et al. (2005). STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 6: 303-313.
33. Sternberg DW, Gilliland DG. (2004). The role of signal transducer and activator of transcription factors in leukemogenesis. J Clin Oncol 22: 361-371.
34. Su L, Rickert RC, David M. (1999). Rapid STAT phosphorylation via the B cell receptor. Modulatory role of CD19. J Biol Chem 274: 31770-31774.
35. 2+ mobilization through distinct pathways. EMBO J 13: 1341-1349.
36. Tweardy DJ, Wright TM, Ziegler SF, Baumann H, Chakraborty A, White SM et al. (1995). Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells. Blood 86: 4409-4416.
37. Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ. (1997). Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc Natl Acad Sci USA 94: 11526-11533.
38. Winding P, Berchtold MW. (2001). The chicken B cell line DT40: a novel tool for gene disruption experiments. J Immunol Methods 249: 1-16.
39. Yi TL, Bolen JB, Ihle JN. (1991). Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus. Mol Cell Biol 11: 2391-2398.
40. You M, Yu DH, Feng GS. (1999). Shp2-tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19: 2416-2424.
41. Yu CL, Jove R, Burakoff SJ. (1997). Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J Immunol 159: 5206-5210.
42. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J et al. (1995). Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81-83.
43. Yu H, Jove R. (2004). The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4: 97-105.